Vosaroxin for Intermediate 2 or High-risk MDS After Failure With Hypomethylating Agent-based Therapy
Clinical trial NCT01980056 · COMPLETED
Trial details
- NCT number
- NCT01980056
- Sponsor
- Weill Medical College of Cornell University
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-25
- Primary completion
- 2015-01-19
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.